"Siemens" amylase analysis reagent set
Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.·Registered Oct 26, 2020 – Oct 26, 2025Expired- Analysis ID
- 63ea93b7e075dedc1c0c47d1d30c1937
- Customs Code
- DHA05603369304
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
- Intended Use
- This product is used in vitro diagnostics with Atellica CH Analyzer to quantitatively detect amylase activity in human serum, plasma (heparin lithium) and urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1070 澱粉酶試驗系統
- Import Information
- QMS/QSD;; 輸入;; 委託製造
- Registration Date
- Oct 26, 2020
- Expiry Date
- Oct 26, 2025
Top companies providing products similar to ""Siemens" amylase analysis reagent set"
Recently registered similar products
Access comprehensive regulatory information for "Siemens" amylase analysis reagent set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 63ea93b7e075dedc1c0c47d1d30c1937 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.